Xenetic Biosciences Inc.
(XBIO)
undefined
undefined%
At close: undefined
4.01
0.00%
After-hours Dec 13, 2024, 02:56 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 2.54M | 1.71M | 1.16M | 436.94K | 17.07K | - | 7.58M | 3.00M | - | - | 1.00M | 293.60K |
Cost of Revenue | - | 27.04K | 35.48K | - | - | 15.83K | 156.12K | 36.45K | 56.12K | - | 8.44K | 44.84K |
Gross Profit | 2.54M | 1.68M | 1.13M | 436.94K | 17.07K | -15.83K | 7.43M | 2.96M | -56.12K | - | 991.57K | 248.76K |
Operating Income | -4.52M | -6.72M | -5.75M | 4.55M | -12.89M | -7.28M | -3.57M | -47.43M | -9.82M | -12.92M | -8.61M | -6.34M |
Interest Income | 355.76K | 167.15K | 100.47K | 126.17K | 216.98K | - | 16.54K | 32.00 | 1.69K | 18.96K | 34.85K | 67.67K |
Pretax Income | -4.13M | -6.55M | -5.65M | -13.81M | -12.78M | -7.30M | -3.60M | -54.21M | -12.51M | -14.31M | -8.58M | -6.33M |
Net Income | -4.13M | -6.39M | -5.54M | -10.89M | -15.95M | -7.30M | -3.60M | -54.21M | -12.51M | -14.31M | -8.58M | -6.33M |
Selling & General & Admin | 3.56M | 3.65M | 3.74M | 3.40M | 4.73M | 4.39M | 6.94M | 6.69M | 6.39M | 6.60M | 6.55M | 3.56M |
Research & Development | 3.49M | 4.77M | 3.16M | 1.73M | 4.89M | 2.88M | 4.06M | 43.74M | 3.43M | 6.32M | 3.06M | 1.94M |
Other Expenses | - | -1.60K | 1.12K | -492 | 3.31K | -24.64K | -41.10K | - | - | - | 68.28K | - |
Operating Expenses | 7.06M | 8.42M | 6.91M | 5.13M | 9.62M | 7.28M | 11.00M | 50.43M | 9.82M | 12.92M | 9.61M | 5.51M |
Interest Expense | - | - | - | - | - | 24.13K | 1.82K | 729.57K | 267.00K | 4.71K | 632.00 | 51.74K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | 112.00K |
Cost & Expenses | 7.06M | 8.42M | 6.91M | 5.13M | 9.62M | 7.28M | 11.15M | 50.43M | 9.82M | 12.92M | 9.61M | 5.55M |
Income Tax | - | -165.56K | -100.47K | -2.92M | 3.17M | 24.13K | 26.37K | 6.05M | 2.42M | 1.40M | -34.22K | 1.09M |
Shares Outstanding (Basic) | 1.53M | 1.42M | 1.03M | 639.24K | 285.25K | 75.59K | 72.21K | 61.92K | 35.20K | 34.32K | 3.03K | 3.02K |
Shares Outstanding (Diluted) | 1.53M | 1.42M | 1.03M | 639.24K | 285.25K | 75.60K | 72.21K | 61.92K | 35.20K | 34.32K | 3.03K | 3.02K |
EPS (Basic) | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.58 | -49.78 | -875.41 | -355.34 | -416.91 | -2.84K | -2.09K |
EPS (Diluted) | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.57 | -49.78 | -875.41 | -355.34 | -416.91 | -2.84K | -2.09K |
EBITDA | -4.52M | -6.72M | -5.71M | -4.69M | -9.58M | -7.26M | -3.57M | -53.44M | -9.77M | -14.21M | -8.53M | -5.04M |
Depreciation & Amortization | - | 27.04K | 35.48K | 28.84K | 27.49K | 15.83K | 23.78K | 36.45K | 56.12K | 88.69K | 52.03K | 104.62K |